1. Home
  2. SONN vs LSF Comparison

SONN vs LSF Comparison

Compare SONN & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • LSF
  • Stock Information
  • Founded
  • SONN N/A
  • LSF 2015
  • Country
  • SONN United States
  • LSF United States
  • Employees
  • SONN N/A
  • LSF N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • LSF Packaged Foods
  • Sector
  • SONN Health Care
  • LSF Consumer Staples
  • Exchange
  • SONN Nasdaq
  • LSF Nasdaq
  • Market Cap
  • SONN 32.4M
  • LSF 27.8M
  • IPO Year
  • SONN N/A
  • LSF 2020
  • Fundamental
  • Price
  • SONN $4.02
  • LSF $2.68
  • Analyst Decision
  • SONN Strong Buy
  • LSF Strong Buy
  • Analyst Count
  • SONN 1
  • LSF 1
  • Target Price
  • SONN $20.00
  • LSF $12.00
  • AVG Volume (30 Days)
  • SONN 773.9K
  • LSF 97.5K
  • Earning Date
  • SONN 12-16-2025
  • LSF 11-10-2025
  • Dividend Yield
  • SONN N/A
  • LSF N/A
  • EPS Growth
  • SONN N/A
  • LSF N/A
  • EPS
  • SONN N/A
  • LSF N/A
  • Revenue
  • SONN $1,000,000.00
  • LSF $48,146,862.00
  • Revenue This Year
  • SONN $5,376.22
  • LSF $21.88
  • Revenue Next Year
  • SONN N/A
  • LSF $20.86
  • P/E Ratio
  • SONN N/A
  • LSF N/A
  • Revenue Growth
  • SONN 1689.52
  • LSF 17.73
  • 52 Week Low
  • SONN $1.08
  • LSF $2.43
  • 52 Week High
  • SONN $19.30
  • LSF $10.90
  • Technical
  • Relative Strength Index (RSI)
  • SONN 44.01
  • LSF 27.63
  • Support Level
  • SONN $3.95
  • LSF $2.47
  • Resistance Level
  • SONN $5.06
  • LSF $2.84
  • Average True Range (ATR)
  • SONN 0.87
  • LSF 0.25
  • MACD
  • SONN -0.08
  • LSF 0.01
  • Stochastic Oscillator
  • SONN 18.83
  • LSF 11.79

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

Share on Social Networks: